Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA in Liver Fibrosis
NCT04727320Phase 1Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial in Liver Fibrosis (LF) and Liver cirrhosis (LC) comparing TUDCA Arm with Placebo Arm (2 arms). Primary endpoint: Liver biopsy at 24 weeks. Status: unknown.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
Liver Fibrosis (LF)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04727320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04727320.